MetaCap

Vera Therapeutics Statistics

NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

25.45-1.30 (-4.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vera Therapeutics by the numbers

Vera Therapeutics has a market capitalization of $1.84 billion based on 72.30M shares outstanding. With trailing EPS of $-5.90, Vera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.9% below its 50-day average and 28.7% below its 200-day average.

Average daily trading volume is 1.95M shares, or about $49.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VERA valuation vs. peer median

VERA compared with the median of 8 peer companies
MetricVERAPeer medianDifference
Market cap$1.84B$1.84B-0%
Avg. volume1.95M1.23M+59%

Peer median across 8 companies: SEPN, IMNM, MRVI, BHVN, ZYME, TRVI, HRMY, ETON.

Valuation

Price and trading

Previous close
26.75
Open
26.37
Day range
25.16 – 27.15
52-week range
25.08 – 56.05
52-week change
-10.58%
Beta
—
Volume
1.37M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.84B
Forward Pe
-6.50
Eps
-5.90
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
56.05
Week52 Low
25.08
Avg Volume
1.95M
Shares Outstanding
72.30M
Ma50
30.25
Ma200
35.71
Earnings Date
Nov 5, 2026
Pct From52w High
-54.59%
Pct From52w Low
1.48%

Related